bcl-2 vs p53 Protein expression and apoptotic rate in human nonmelanoma skin cancers

Archives of Dermatology

Volumn 133, Issue 5, 1997, Pages 599-602

  Wikonkal, Norbert M ^a,b   Berg, Rob J W ^a   Van Haselen, Christian W ^a   Horkay, Irene ^b   Remenyik, Eva ^a,c   Begany, Agnes ^a,c   Hunyadi, Janos ^a,c   Van Vloten, Willem A ^a   De Gruijl, Frank R ^a,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

APOPTOSIS; ARTICLE; BASAL CELL CARCINOMA; CARCINOGENESIS; CELL TRANSFORMATION; CLINICAL ARTICLE; GENE EXPRESSION; GENOTOXICITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CANCER; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; TUMOR GROWTH;

EID: 0030992807     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.5.599     Document Type: Article

References (33)

1. Wyllie A. The genetic regulation of apoptosis. Curr Opin Genet Dev. 1995;5:97-104.
2. Ziegler A, Jonason AS, Leffell DJ, et al. Sunburn and p53 in onset of skin cancer. Nature. 1994;372:773-776.
3. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of human bax gene. Cell. 1995;80:293-299.
4. Yuspa SH. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis - 33rd G. H. A. Clowes Memorial Award Lecture, Cancer Res. 1994;54:1178-1189.
5. Hengartner MO, Horvitz HR. Activation of C elegans cell death protein CEO-9 by an amino-acid substitution in a domain conserved in Bcl-2. Nature. 1994;369:318-320.
6. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 Is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990;348:334-336.
7. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerlzes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74:609-619.
8. Agular-Santelis M, Rottenberg ME, Lewin N, Mellstedt H, Jondal M. Bcl-2, bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression. Int J Cancer. 1996;69:114-119.
9. Miyashita T, Krajewski S, Krajewska M, et al. Tumour suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994;9:1799-1805.
10. Wang Y, Szekely L, Okan I, Klein G, Wiman KG. Wild-type p-53 triggered apoptosis is inhibited by bcl-2 in a v-myc induced T-cell lymphoma line. Oncogene. 1993;8:3427-3431.
11. Steller H. Mechanisms and genes of cellular suicide, Science. 1995;267:1445-1449.
12. Brash DE, Rudolph JA, Simon JAB, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A 1991;88:10124-10128.
13. Nagano T, Ueda M, Ichihashi M. Expression of p53 protein is an early event in ultraviolet light-induced cutaneous squamous cell carcinogenesis. Arch Dermatol. 1993;129:1157-1161.
14. Moles JP, Moyret C, Guillot B, et al. p53 gene mutations in human epithelial skin cancers. Oncogene. 1993;8:583-588.
15. Basset Seguin N, Moles JP, Mils V, Dereure O, Guilhou JJ, TP53 tumor suppressor gene and skin carcinogenesis. J Invest Dermatol. 1994;103:102S-106S.
16. Hetander SD, Peters MS, Pittelkow MR, Expression of p53 protein in benign and malignant epidermal pathologic conditions, J Am Acad Dermatol. 1993;29:741-748.
17. McGregor JM, Yu CC, Dublin EA, Levison DA, MacDonald DM. Aberrant expression of p53 tumour-suppressor protein in non-melanoma skin cancer. Br J Dermatol. 1992;127:463-469.
18. Stephenson TJ, Royds J, Silcocks PB, Bleehen SS. Mutant p53 oncogens expression in keratoacanthoma and squamous cell carcinoma. Br J Dermatol. 1992;127:566-570.
19. Ziegler A, Leffell DJ, Kunala S, et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A. 1993:90:4216-4220.
20. Cattoretti G, Pileri S, Parravicini C, et al. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol. 1993;171:83-98.
21. Campbell C, Quinn AG, Angus B, Rees JL The relation between p53 mutation and p53 immunostaining in non-melanoma skin cancer. Br J Dermatol. 1993;129:235-241.
22. Nakagawa K, Yamamura K, Maeda S, Ichihashi M. bcl-2 expression in epidermal keratinocytic diseases, Cancer. 1994;74:1720-1724.
23. Polakowska RR, Piacentini M, Bartlett R, Goldsmith LA, Haake AR. Apoptosis In human skin development: morphogenesis, periderm, and stem cells, Dev Dyn. 1994;199:176-188.
24. Mooney EEJ, Ruls Peris JM, O'Neill A, Sweeney EC. Apoptotic and mitotic indices in malignant melanoma and basal cell carcinoma. J Clin Pathol. 1995;48:242-244.
25. Cerroni L, Kerl H. Aberrant bcl-2 protein expression provides a possible mechanism of neoplastic cell growth in cutaneous basal-cell carcinoma. J Cutan Pathol. 1994;21:398-403.
26. Morales-Ducret CR, van de Rijn M, LeBrun DP, Smoller BR. bcl-2 expression in primary malignancies of the skin. Arch Dermatol. 1995;131:909-912.
27. Sleater JP, Beers BB, Stephens CA, Hendricks JB. Keratoacanthoma: a deficient squamous cell carcinoma? study of bcl-2 expression. J Cutan Pathol. 1994;21:514-519.
28. Verhaegh ME, Sanders CJ, Arends JW, Neumann HA. Expression of the apoptosis-suppressing protein Bcl-2 in non-melanoma skin cancer. Br J Dermatol. 1995;132:740-744.
29. Weedon D. Apoptosis. Adv Dermatol. 1990;5:243-256.
30. Haake AR, Polakowska RR. Cell death by apoptosis in epidermal biology. J Invest Dermatol. 1993;101:107-112.
31. Chetty R, O'Leary JJ, Biddolf SC, Gatter KC. Immunohistochemical detection of p53 and Bcl-2 proteins in Hashimoto's thyroiditis and primary thyroid lymphomas. J Clin Pathol. 1995;48:239-241.
32. Sinicrope FA, Bao RS, Cleary KR, Stephens LC, Lee N, Levin B, bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 1995;55:237-241.
33. Brady HJ, Salomons GS, Bobeldijk RC, Berns AJ. T cells from bax-alpha transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in absence of p53. EMBO J. 1996;15:1221-1230.